52517
1,1,1,3,3,3-Hexafluoro-2-propanol
derivatization grade (GC derivatization), LiChropur™, ≥99.8%
동의어(들):
HFP, Hexafluoroisopropanol
조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
보기 변경
제품정보 (DICE 배송 시 비용 별도)
Linear Formula:
(CF3)2CHOH
CAS 번호:
Molecular Weight:
168.04
UNSPSC Code:
12352104
NACRES:
NA.05
PubChem Substance ID:
EC Number:
213-059-4
Beilstein/REAXYS Number:
1841007
MDL number:
Assay:
≥99.8% (GC), ≥99.8%
grade
derivatization grade (GC derivatization)
Quality Level
assay
≥99.8% (GC), ≥99.8%
quality
LiChropur™
reaction suitability
reagent type: derivatization reagent
reaction type: Acylations, reagent type: derivatization reagent
reaction type: Esterifications
technique(s)
gas chromatography (GC): suitable
refractive index
n20/D 1.275 (lit.)
bp
59 °C (lit.)
mp
−4 °C (lit.)
density
1.596 g/mL at 25 °C (lit.)
SMILES string
OC(C(F)(F)F)C(F)(F)F
InChI
1S/C3H2F6O/c4-2(5,6)1(10)3(7,8)9/h1,10H
InChI key
BYEAHWXPCBROCE-UHFFFAOYSA-N
General description
Hexafluoroisopropanol (HFP) is generally used to denature the native state of proteins, and it also stabilizes the a-helical conformation in unfolded peptides and proteins like β-lactoglobulin and melittin.
Application
Suitable for the derivatization of glutamic acid, homovanillic, iso-homovanillic and dihydroxyphenyl acetic acids and Υ-aminobutyric acid.
Other Notes
Reagent for hexafluoroisopropyl ester, N-pentafluoropropionyl, and trifluoroacetyl..
Size-exclusion chromatography in 1,1,1,3,3,3-hexafluoro-2-propanol
Legal Information
LiChropur is a trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Repr. 2 - Skin Corr. 1A - STOT RE 2
저장 등급
8A - Combustible corrosive hazardous materials
wgk
WGK 2
flash_point_f
No data available
flash_point_c
No data available
ppe
Faceshields, Gloves, Goggles
Jie Zhu et al.
Journal of enzyme inhibition and medicinal chemistry, 33(1), 496-506 (2018-02-07)
The cholinergic hypothesis has long been a "polar star" in drug discovery for Alzheimer's disease (AD), resulting in many small molecules and biological drug candidates. Most of the drugs marketed for AD are cholinergic. Herein, we report our efforts in
Sriya Das et al.
ACS applied materials & interfaces, 3(6), 1844-1851 (2011-05-05)
We demonstrate a novel in situ polymerization technique to develop localized polymer coatings on the surface of dispersed pristine graphene sheets. Graphene sheets show great promise as strong, conductive fillers in polymer nanocomposites; however, difficulties in dispersion quality and interfacial
Yao Chen et al.
Journal of enzyme inhibition and medicinal chemistry, 33(1), 290-302 (2017-12-28)
Small molecule cholinesterases inhibitor (ChEI) provides an effective therapeutic strategy to treat Alzheimer's disease (AD). Currently, the discovery of new ChEI with multi-target effect is still of great importance. Herein, we report the synthesis, structure-activity relationship study and biological evaluation